Compile Data Set for Download or QSAR
Report error Found 272 Enz. Inhib. hit(s) with all data for entry = 9972
TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287686(US10085984, Example 64 | US11040034, Ex. No. 64)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287751(US10085984, Example 129 | US11040034, Ex. No. 129)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287688(US10085984, Example 66 | US11040034, Ex. No. 66)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287689(US10085984, Example 67 | US11040034, Ex. No. 67)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287626(US10085984, Example 4 | US11040034, Ex. No. 4)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287691(US10085984, Example 69 | US11040034, Ex. No. 69)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287692(US10085984, Example 70 | US11040034, Ex. No. 70)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287628(US10085984, Example 6 | US11040034, Ex. No. 6)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287693(US10085984, Example 71 | US11040034, Ex. No. 71)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287629(US10085984, Example 7 | US11040034, Ex. No. 7)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287742(US10085984, Example 120 | US11040034, Ex. No. 120)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287679(US10085984, Example 57 | US11040034, Ex. No. 57)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287743(US10085984, Example 121 | US11040034, Ex. No. 121)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287680(US10085984, Example 58 | US11040034, Ex. No. 58)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287744(US10085984, Example 122 | US11040034, Ex. No. 122)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287681(US10085984, Example 59 | US11040034, Ex. No. 59)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287745(US10085984, Example 123 | US11040034, Ex. No. 123)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287746(US10085984, Example 124 | US11040034, Ex. No. 124)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287683(US10085984, Example 61 | US11040034, Ex. No. 61)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287747(US10085984, Example 125 | US11040034, Ex. No. 125)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287684(US10085984, Example 62 | US11040034, Ex. No. 62)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287685(US10085984, Example 63 | US11040034, Ex. No. 63)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287749(US10085984, Example 127 | US11040034, Ex. No. 127)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287703(US10085984, Example 81 | US11040034, Ex. No. 81)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287640(US10085984, Example 18 | US11040034, Ex. No. 18)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287705(US10085984, Example 83 | US11040034, Ex. No. 83)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287641(US10085984, Example 19 | US11040034, Ex. No. 19)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM504406(US11040034, Ex. No. 84)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287707(US10085984, Example 85 | US11040034, Ex. No. 85)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287643(US10085984, Example 21 | US11040034, Ex. No. 21)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287708(US10085984, Example 86 | US11040034, Ex. No. 86)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287644(US10085984, Example 22 | US11040034, Ex. No. 22)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287709(US10085984, Example 87 | US11040034, Ex. No. 87)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287645(US10085984, Example 23 | US11040034, Ex. No. 23)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B1, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287709(US10085984, Example 87 | US11040034, Ex. No. 87)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287694(US10085984, Example 72 | US11040034, Ex. No. 72)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287758(US10085984, Example 136 | US11040034, Ex. No. 136)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287696(US10085984, Example 74 | US11040034, Ex. No. 74)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287632(US10085984, Example 10 | US11040034, Ex. No. 10)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287697(US10085984, Example 75 | US11040034, Ex. No. 75)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287633(US10085984, Example 11 | US11040034, Ex. No. 11)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287698(US10085984, Example 76 | US11040034, Ex. No. 76)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287634(US10085984, Example 12 | US11040034, Ex. No. 12)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287636(US10085984, Example 14 | US11040034, Ex. No. 14)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287637(US10085984, Example 15 | US11040034, Ex. No. 15)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287654(US10085984, Example 32 | US11040034, Ex. No. 32)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287719(US10085984, Example 97 | US11040034, Ex. No. 97)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287655(US10085984, Example 33 | US11040034, Ex. No. 33)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B1, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287719(US10085984, Example 97 | US11040034, Ex. No. 97)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

TargetCytochrome P450 11B2, mitochondrial(Human)
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287656(US10085984, Example 34 | US11040034, Ex. No. 34)
Affinity DataIC50: 50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2021
Entry Details
US Patent

Displayed 1 to 50 (of 272 total ) | Next | Last >>
Jump to: